AI assistant
Sending…
LISATA THERAPEUTICS, INC. — Director's Dealing 2014
Jul 17, 2014
34931_dirs_2014-07-17_7b932d83-a40a-4b3f-aa19-c17dabdd0478.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NeoStem, Inc. (NBS)
CIK: 0000320017
Period of Report: 2014-07-17
Reporting Person: Pecora Andrew L (Director, Chief Visionary Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-07-17 | Common Stock, $0.001 par value | A | 606 | $5.90 | Acquired | 274831 | Direct |
Footnotes
F1: Shares purchased pursuant to NeoStem, Inc.'s 2012 Employee Stock Purchase Plan for the period ended June 30, 2014.